Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells
Wissing, Michel D, Mendonca, Janet, Kim, Eunice, Kim, Eugene, Shim, Joong S., Kaelber, Nadine S., Kant, Huub, Hammers, Hans, Commes, Therese, Van Diest, Paul J., Liu, Jun O., Kachhap, Sushant K.Volume:
14
Language:
english
Journal:
Cancer Biology & Therapy
DOI:
10.4161/cbt.23759
Date:
May, 2013
File:
PDF, 5.90 MB
english, 2013